BENZODIAZEPINE DRUGS MARKET ANALYSIS

Benzodiazepine Drugs Market, By Product (Long Acting Benzodiazepines (Chlordiazepoxide, Diazepam, Lorazepam, Alprazolam, Clonazepam, Others) and Short Acting Benzodiazepines), By Route of Administration (Oral, Injectables, Others), By Application (Anxiety Disorders, Nervousness, Sedation, Seizures, Alcohol Withdrawal, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

Published In : Feb 2025
Code : CMI5001
Pages :208
Formats :
Excel and PDF
Industry : Pharmaceutical

Market Concentration and Competitive Landscape

Close-monitor your Competitor's Move, Request sample copy

Increasing Product Approvals by the Regulatory Authorities

Increasing product approvals by the regulatory authorities is expected to drive the global benzodiazepine drugs market growth over the forecast period. For instance, in August 2021, Loreev XR (extended-release lorazepam) distributed by Almatica Pharma LLC (a U.S.-based pharmaceutical company), was approved by the U.S. Food and Drug Administration (FDA). It is a once daily benzodiazepine formulation that is indicated for the treatment of anxiety disorders, preoperative sedation, anterograde amnesia, and status epilepticus in adults.

Key Players Insights